The Effect of a Synthetic Hexadentate Iron Chelator (CP130) and Desferrioxamine on Rabbit Kidneys Exposed to Cold and Warm Ischaemia

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1993 Sep 1

PMID 8147275

Authors

J D Gower

I J Ambrose

S Manek

J Bright

P S Dobbin

R C Hider

J G Goddard

M S Thorniley

C J Green

Affiliations

Soon will be listed here.

Abstract

The effect of CP130 (a synthetic hexadentate pyridinone iron chelator) on the formation of two markers of lipid peroxidation (TBA-reactive material and Schiff's bases) in rabbit kidneys following a 72 h period of cold (0-4 degrees C) ischaemia was investigated by either adding CP130 to the flush/storage solution (hypertonic citrate solution) or by administering the agent intravenously 15 min before removal of the organs. In both cases, CP130 blocked the adverse rises in lipid peroxidation caused by ischaemia and subsequent reoxygenation of the homogenates in vitro. Both CP130 and desferrioxamine (DFX) (administered intravenously 15 min before ischaemia and 5 min before reperfusion) were also found to significantly reduce post-ischaemic rates of in vitro lipid peroxidation in kidneys rendered warm ischaemic for 90 min followed by reperfusion for 5 or 60 min in situ. Kidneys exposed to warm ischaemia and reperfusion developed interstitial and intracellular oedema, congestion and haemorrhage. DFX administration had little effect on the histological outcome, whereas CP130 significantly reduced interstitial oedema (at 5 min reperfusion compared to the DFX-treated group), intracellular oedema (at 60 min reperfusion compared to the DFX-treated group) and congestion (at 5 min reperfusion compared with a control group not given any agent). It is concluded that while CP130 and DFX exhibited similar antioxidant properties, CP130 provided better protection from ischaemia/reperfusion injury at the histological level. Synthetic iron chelators may therefore be of benefit in clinical organ transplantation by protecting against tissue damage caused by prolonged ischaemia.

References

Ploeg R, Vreugdenhil P, Goossens D, McAnulty J, Southard J, Belzer F . Effect of pharmacologic agents on the function of the hypothermically preserved dog kidney during normothermic reperfusion. Surgery. 1988; 103(6):676-83. View

Williams R, Zweier J, Flaherty J . Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation. 1991; 83(3):1006-14. DOI: 10.1161/01.cir.83.3.1006. View

Gower J, Healing G, Fuller B, Simpkin S, Green C . Protection against oxidative damage in cold-stored rabbit kidneys by desferrioxamine and indomethacin. Cryobiology. 1989; 26(4):309-17. DOI: 10.1016/0011-2240(89)90054-0. View

Ross H, Marshall V, Escott M . 72-hr canine kidney preservation without continuous perfusion. Transplantation. 1976; 21(6):498-501. DOI: 10.1097/00007890-197606000-00009. View

Galinanes M, Hearse D . Diltiazem and/or desferrioxamine administered at the time of reperfusion fail to improve post-ischemic recovery in the isolated rat heart after long-term hypothermic storage. J Mol Cell Cardiol. 1990; 22(11):1211-20. DOI: 10.1016/0022-2828(90)90058-a. View

Granger D, BENOIT J, Suzuki M, Grisham M . Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol. 1989; 257(5 Pt 1):G683-8. DOI: 10.1152/ajpgi.1989.257.5.G683. View

Rosenthal J, Danovitch G, Wilkinson A, Ettenger R . The high cost of delayed graft function in cadaveric renal transplantation. Transplantation. 1991; 51(5):1115-8. View

Gower J, Healing G, Green C . Measurement by HPLC of desferrioxamine-available iron in rabbit kidneys to assess the effect of ischaemia on the distribution of iron within the total pool. Free Radic Res Commun. 1989; 5(4-5):291-9. DOI: 10.3109/10715768909074713. View

Nayini N, White B, Aust S, Huang R, Indrieri R, Evans A . Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrest. J Free Radic Biol Med. 1985; 1(2):111-6. DOI: 10.1016/0748-5514(85)90014-5. View

10.

Okunade G, Khan R . The suppression of iron release from activated myoglobin by physiological electron donors and by desferrioxamine. Free Radic Res Commun. 1989; 7(1):45-54. DOI: 10.3109/10715768909088161. View

11.

Toffa S, Cheetham K, Fuller B, Gower J, Green C . A study of the distribution of desferrioxamine in the isolated perfused rabbit kidney. Biochem Soc Trans. 1991; 19(2):217S. DOI: 10.1042/bst019217s. View

12.

KEBERLE H . THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM. Ann N Y Acad Sci. 1964; 119:758-68. DOI: 10.1111/j.1749-6632.1965.tb54077.x. View

13.

Green C, Healing G, Simpkin S, Fuller B, Lunec J . Reduced susceptibility to lipid peroxidation in cold ischemic rabbit kidneys after addition of desferrioxamine, mannitol, or uric acid to the flush solution. Cryobiology. 1986; 23(4):358-65. DOI: 10.1016/0011-2240(86)90040-4. View

14.

Paller M, Hedlund B . Role of iron in postischemic renal injury in the rat. Kidney Int. 1988; 34(4):474-80. DOI: 10.1038/ki.1988.205. View

15.

Halliwell B . Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Its role in degradation of hyaluronic acid by a superoxide-generating system. FEBS Lett. 1978; 96(2):238-42. DOI: 10.1016/0014-5793(78)80409-8. View

16.

van der Kraaij A, van Eijk H, Koster J . Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3. Circulation. 1989; 80(1):158-64. DOI: 10.1161/01.cir.80.1.158. View

17.

Conte Jr J, Katz N, Foegh M, Wallace R, RAMWELL P . Iron chelation therapy and lung transplantation. Effects of deferoxamine on lung preservation in canine single lung transplantation. J Thorac Cardiovasc Surg. 1991; 101(6):1024-9. View

18.

Streater M, Taylor P, Hider R, Porter J . Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity. J Med Chem. 1990; 33(6):1749-55. DOI: 10.1021/jm00168a033. View

19.

Fuller B, Gower J, Green C . Free radical damage and organ preservation: fact or fiction? A review of the interrelationship between oxidative stress and physiological ion disbalance. Cryobiology. 1988; 25(5):377-93. DOI: 10.1016/0011-2240(88)90046-6. View

20.

Green C, Healing G, Simpkin S, Lunec J, Fuller B . Desferrioxamine reduces susceptibility to lipid peroxidation in rabbit kidneys subjected to warm ischaemia and reperfusion. Comp Biochem Physiol B. 1986; 85(1):113-7. DOI: 10.1016/0305-0491(86)90230-0. View